1. Home
  2. ORMP vs ASMB Comparison

ORMP vs ASMB Comparison

Compare ORMP & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • ASMB
  • Stock Information
  • Founded
  • ORMP 2002
  • ASMB 2005
  • Country
  • ORMP United States
  • ASMB United States
  • Employees
  • ORMP N/A
  • ASMB N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • ASMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORMP Health Care
  • ASMB Health Care
  • Exchange
  • ORMP Nasdaq
  • ASMB Nasdaq
  • Market Cap
  • ORMP 90.7M
  • ASMB 84.5M
  • IPO Year
  • ORMP N/A
  • ASMB 2010
  • Fundamental
  • Price
  • ORMP $2.17
  • ASMB $13.42
  • Analyst Decision
  • ORMP Hold
  • ASMB Buy
  • Analyst Count
  • ORMP 1
  • ASMB 2
  • Target Price
  • ORMP N/A
  • ASMB $35.00
  • AVG Volume (30 Days)
  • ORMP 113.9K
  • ASMB 22.6K
  • Earning Date
  • ORMP 03-05-2025
  • ASMB 03-27-2025
  • Dividend Yield
  • ORMP N/A
  • ASMB N/A
  • EPS Growth
  • ORMP N/A
  • ASMB N/A
  • EPS
  • ORMP 0.11
  • ASMB N/A
  • Revenue
  • ORMP N/A
  • ASMB $28,326,000.00
  • Revenue This Year
  • ORMP N/A
  • ASMB $282.16
  • Revenue Next Year
  • ORMP N/A
  • ASMB N/A
  • P/E Ratio
  • ORMP $19.82
  • ASMB N/A
  • Revenue Growth
  • ORMP N/A
  • ASMB N/A
  • 52 Week Low
  • ORMP $2.00
  • ASMB $9.84
  • 52 Week High
  • ORMP $3.67
  • ASMB $19.93
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 36.05
  • ASMB 40.25
  • Support Level
  • ORMP $2.12
  • ASMB $13.60
  • Resistance Level
  • ORMP $2.27
  • ASMB $14.25
  • Average True Range (ATR)
  • ORMP 0.07
  • ASMB 0.58
  • MACD
  • ORMP -0.01
  • ASMB -0.05
  • Stochastic Oscillator
  • ORMP 22.73
  • ASMB 5.93

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: